Located in Malvern, PA, this 104,400 SF building was renovated in 2008 and acquired by Warren Avenue Investors in 2017.
This now-fully leased building provides investment grade and international tenants with high-quality lab, R&D, and flexible office space to serve their needs. With proximity to major life sciences players such as Johnson & Johnson, Merck, and Teva, as well as its easy access to four major highways, the building is well positioned for long-term growth.